ConductScience.org, home

Paper8909427

Neuropsychiatric aspects of progressive supranuclear palsy.

Litvan I and 3 others. Neurology, 1996. Cited by 173 papers, by iCite.

Cite this record

ConductScience Library. Neuropsychiatric aspects of progressive supranuclear palsy. Papers, record 8909427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8909427

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuropsychiatric aspects of progressive supranuclear palsy.
PubMed
Journal
Neurology
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
173
iCite
Relative citation ratio, by iCite
6.04
iCite
Revised in PubMed
2019-05-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Litvan II
2Mega MSM S
3Cummings JLJ L
4Fairbanks LL

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Supranuclear Palsy, ProgressiveMajor topic
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Neuropsychological Tests
Psychiatric Status Rating Scales

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AG10123NIA NIH HHSUnited StatesP30AG010123PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.

PMIDTitleJournalYearIn PapersSource
41674844Cholinergic substrates of gait and postural impairments in Progressive Supranuclear Palsy.Res Sq2026https://conductscience.org/library/papers/41674844PubMed
41553623Dementia in Progressive Supranuclear Palsy: A Narrative Review.Neurol Ther2026https://conductscience.org/library/papers/41553623PubMed
40389915Comparative study of nonmotor symptoms in progressive supranuclear palsy and Parkinson's disease.BMC Neurol2025https://conductscience.org/library/papers/40389915PubMed
40384451Evaluating the Homogeneity of the PSP-RS Syndrome beyond Core Features.Mov Disord Clin Pract2025https://conductscience.org/library/papers/40384451PubMed
39954076Pathomechanisms of neuropsychiatric disturbances in atypical parkinsonian disorders: a current view.J Neural Transm (Vienna)2025https://conductscience.org/library/papers/39954076PubMed
39579261Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET.Neurol Sci2025https://conductscience.org/library/papers/39579261PubMed
39372876SEND-PD in Parkinsonian Syndromes: Results of a Monocentric Cross-Sectional Study.Neuropsychiatr Dis Treat2024https://conductscience.org/library/papers/39372876PubMed
38868471Late-life mood disorder as the initial presentation of progressive supranuclear palsy: A case series.PCN Rep2024https://conductscience.org/library/papers/38868471PubMed
38500811Behavioral disinhibition in stroke.Front Neurol2024https://conductscience.org/library/papers/38500811PubMed
38391755Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?Brain Sci2024https://conductscience.org/library/papers/38391755PubMed
37594689Let Us Talk Money: Subjectively Reported Financial Performance of People Living with Neurodegenerative Diseases-A Systematic Review.Neuropsychol Rev2024https://conductscience.org/library/papers/37594689PubMed
37535119Frequency and imaging correlates of neuropsychiatric symptoms in Progressive Supranuclear Palsy.J Neural Transm (Vienna)2023https://conductscience.org/library/papers/37535119PubMed
35874938Integrated case-based clinical approach in understanding pathways, complexities, pitfalls and challenges in neurodegenerative disorders.Am J Neurodegener Dis2022https://conductscience.org/library/papers/35874938PubMed
34761056Co-Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy.Mov Disord Clin Pract2021https://conductscience.org/library/papers/34761056PubMed
34296340Caregiver strain in progressive supranuclear palsy and corticobasal syndromes.J Neural Transm (Vienna)2021https://conductscience.org/library/papers/34296340PubMed
33704556Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.J Neurol2021https://conductscience.org/library/papers/33704556PubMed
33163568Two Patients with Niemann Pick Disease Type C Diagnosed in the Seventh Decade of Life.Mov Disord Clin Pract2020https://conductscience.org/library/papers/33163568PubMed
32919754Cognitive and behavioural inhibition deficits in neurodegenerative dementias.Cortex2020https://conductscience.org/library/papers/32919754PubMed
32013737The Neuropsychiatric Inventory: Development and Applications.J Geriatr Psychiatry Neurol2020https://conductscience.org/library/papers/32013737PubMed
31229940Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy.Neuroimage Clin2019https://conductscience.org/library/papers/31229940PubMed

See all 68 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8909427

GET https://conductscience.org/api/papers/v1/8909427/cited_by?page=2